Mullan Pharmaceutical
U.S.-based pharmaceutical company supplying FDA-approved generic and specialty medicines to hospitals, health systems, pharmacies, government agencies, distributors, and other healthcare organizations. The company focuses on distribution, manufacturing partnerships, regulatory registration support, quality management, and supply reliability. Product types include sterile injectables, prefilled syringes, oral solids, and volatile anesthetic formulations. The company also operates a public-health harm-reduction program.
Industries
Nr. of Employees
small (1-50)
Mullan Pharmaceutical
Products
Sevoflurane USP, 250 mL
Volatile liquid inhalation anesthetic supplied in bottles for use with appropriate vaporization equipment; intended for induction and maintenance of general anesthesia.
Ganirelix Acetate Injection, 250 mcg/0.5 mL (prefilled syringe)
GnRH antagonist supplied as a single-dose prefilled syringe for controlled ovarian stimulation in fertility treatment.
Amikacin Sulfate Injection, USP (500 mg/2 mL; 1000 mg/4 mL)
Aminoglycoside antibacterial injection supplied in single vials and cartons; intended as an anti-infective for serious infections.
Representative generic oral and injectable products
Catalog of FDA-approved generic pharmaceutical products across multiple therapeutic areas (examples include metformin, gabapentin, bupropion, celecoxib, argatroban, bumetanide, labetalol).
Labetalol Hydrochloride Injection, USP
Labetalol Hydrochloride Injection, USP offered by Mullan Pharmaceutical.
Sevoflurane, USP
Sevoflurane, USP offered by Mullan Pharmaceutical.
Sevoflurane USP, 250 mL
Volatile liquid inhalation anesthetic supplied in bottles for use with appropriate vaporization equipment; intended for induction and maintenance of general anesthesia.
Ganirelix Acetate Injection, 250 mcg/0.5 mL (prefilled syringe)
GnRH antagonist supplied as a single-dose prefilled syringe for controlled ovarian stimulation in fertility treatment.
Amikacin Sulfate Injection, USP (500 mg/2 mL; 1000 mg/4 mL)
Aminoglycoside antibacterial injection supplied in single vials and cartons; intended as an anti-infective for serious infections.
Representative generic oral and injectable products
Catalog of FDA-approved generic pharmaceutical products across multiple therapeutic areas (examples include metformin, gabapentin, bupropion, celecoxib, argatroban, bumetanide, labetalol).
Labetalol Hydrochloride Injection, USP
Labetalol Hydrochloride Injection, USP offered by Mullan Pharmaceutical.
Sevoflurane, USP
Sevoflurane, USP offered by Mullan Pharmaceutical.
Services
Coordination with qualified contract manufacturers to produce pharmaceutical products at scale for hospital and commercial clients.
Support for product registration and compliance with applicable regulatory requirements across markets.
Partnerships with global transportation and storage providers to manage resilient, on-time supply chains for pharmaceutical products.
Operation of a harm-reduction vending and public-health solutions program to support community health initiatives.
Coordination with qualified contract manufacturers to produce pharmaceutical products at scale for hospital and commercial clients.
Support for product registration and compliance with applicable regulatory requirements across markets.
Partnerships with global transportation and storage providers to manage resilient, on-time supply chains for pharmaceutical products.
Operation of a harm-reduction vending and public-health solutions program to support community health initiatives.
Expertise Areas
- Pharmaceutical distribution and supply chain
- Generic pharmaceuticals
- Hospital and specialty injectables
- Anesthesia and volatile anesthetic supply
Key Technologies
- Sterile injectable formulation and vial filling
- Prefilled syringe assembly
- Volatile liquid anesthetic formulation (inhalation anesthetic)
- Regulatory dossier and drug registration preparation
News & Updates
Announcement of commercial availability of ganirelix acetate injection (250 mcg/0.5 mL) supplied as a single-dose prefilled syringe; availability to healthcare providers and distribution partners in the U.S.
Announcement of U.S. commercial launch of sevoflurane USP, 250 mL, expanding the company's anesthesia and hospital product offerings.
Announcement of U.S. launch of amikacin sulfate injection in 500 mg/2 mL and 1000 mg/4 mL strengths to expand the company's anti-infective portfolio.
Accreditation by the National Coalition for Drug Quality & Security for the facility at Pasadena, CA (period May 23, 2025 to May 23, 2028).
Listed member of an alliance working on drug shortages.
Announcement of commercial availability of ganirelix acetate injection (250 mcg/0.5 mL) supplied as a single-dose prefilled syringe; availability to healthcare providers and distribution partners in the U.S.
Announcement of U.S. commercial launch of sevoflurane USP, 250 mL, expanding the company's anesthesia and hospital product offerings.
Announcement of U.S. launch of amikacin sulfate injection in 500 mg/2 mL and 1000 mg/4 mL strengths to expand the company's anti-infective portfolio.
Accreditation by the National Coalition for Drug Quality & Security for the facility at Pasadena, CA (period May 23, 2025 to May 23, 2028).
Listed member of an alliance working on drug shortages.